Vimarsana
Biggest News Aggregation in the World

Inflammatory Disorders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inflammatory Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inflammatory Disorders Today - Breaking & Trending Today

New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease - Vimarsana News

New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease

WILMINGTON, Del.--(BUSINESS WIRE)--May 19, 2024--

AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024 - Vimarsana News

AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International...

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio - Vimarsana News

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

New data for TEZSPIRE and BREZTRI demonstrate AstraZeneca’s innovation and commitment to transform care in COPD ...

Neotame In Cakes And Drinks Linked To Gut Wall Damage, Scientists Discover - Vimarsana News

Neotame In Cakes And Drinks Linked To Gut Wall Damage, Scientists Discover

Recent research has revealed that neotame, part of the newer generation of artificial sweeteners, can harm the human intestine and induce illness.

Source: ndtv.com
Gilead Sciences 'strengthens commitment' to inflammatory disease with new research site - Vimarsana News

Gilead Sciences 'strengthens commitment' to inflammatory disease with new research site

Gilead Sciences has celebrated the opening of its new research site at the Business Park in Oxford with a ribbon-cutting event.